Epithelial ingrowth (EI) is a severe and incompletely understood complication after laser-assisted in situ keratomileusis (LASIK). Its incidence is variable and cases requiring surgical removal occur with a frequency of 0.92%e2.2%. 1 2 Here, we report the clinical, morphological and immunohistological features of EI cells of four patients, two LASIKs, one FemtoLASIK and one ALTK, with EI that needed surgical removal ( figure  1A) . Immunohistochemistry was performed using antibodies against CK3, Muc5AC, CK15 and CK19 (differentiation markers) and against p63, BMI1, C/EBP d and BCRP/ ABCG2 (stem cell markers) and Ki67 (proliferation marker). 3 Cytoplasm of superficial squamous cells strongly expressed CK3 with no expression of Muc5AC, CK19 or CK15. Nuclear expression of BMI1, p63 a and k and C/EBP d was seen in a majority of cells on EI specimens tested. BCRP/ABCG2 was expressed on the cell membrane and in the cytoplasm and in the nucleus ( figure 1B ).
There are two hypotheses in the literature to explain the mechanism of EI. The first hypothesis suggests that epithelial cells are introduced in the interface of the corneal flap from the periphery of the cornea. This could happen during cutting, lifting or manipulating the flap. The second hypothesis suggests that EI results from cells migrating continuously from the border of the flap to maintain the epithelial cells in the area of the ingrowth. 2 4 In our cases, EI were separated by a clear area from the flap edge with no visible connection to the surface epithelium. This was confirmed by in vivo confocal microscopy in patient N82 ( figure 2A) . In patient N81, the EI was located at the midpoint of a superior hinge more than 2 mm away from the nearest flap edge. These results are in favour of the first hypothesis: EI is an iatrogenic introduction of peripheral corneal epithelial cells in the interface of the flap during surgery ( figure 2B ). Theoretically, in the periphery of the cornea, epithelial cells are transient amplifying cells (TAC) with a limited potential of self-renewal and no expression of limbal stem cells markers. Surprisingly, our results showed that EI can survive for a long time, up to 36 months, which could not be explained by the limited proliferation potential of TAC, but could only be explained by the presence of cells with stem cell properties in the EI. Furthermore, we showed that these cells are positive for putative stem cells markers ( figure 1B) . Taken together, these results suggest that epithelial cells in the EI have stem cells or 'stem-like' cells characteristics. These results address another comment: epithelial stem cells in the EI should come from the periphery of the cornea that was reported to be pluripotent epithelial-progenitor cell-free. This postulate is not always true according to recent data in the literature that have shown in mammals the presence of epithelial stem cells throughout the ocular surface. We have published experimental data in animal models that indicate the existence of oligopotent stem cells in the whole corneal epithelium of mammals, suggesting that the renewal of central corneal epithelium is not different from other squamous epithelia. 5 Moreover, clinical reports of the persistence of a clear central corneal epithelium despite a 3608 rim of limbal stem cell deficiency provide additional support to the presence of stem or stem-like cells both in the limbus and cornea. 6 In this study, we present new results that support the first hypothesis. Clinical features of EI (longevity and cells phenotype) are explained by sliding under the flap during surgery corneal epithelial stem cells from the periphery of the cornea ( figure 2C) .
These observations need to be confirmed by additional clinical and experimental data. 
